Award Winning Publications, Books & Study Guides for Clinical Clinicians

The authors of a small, placebo-controlled study of 24 weeks of dapagliflozin therapy in patients with heart failure with preserved ejection fraction reported reductions in pulmonary capillary wedge pressure, which may explain the reductions in heart failure hospitalizations or cardiovascular death ...

Among participants living with HIV who are at low-to-moderate risk for cardiovascular disease, those who received pitavastatin were 35% less likely to experience a major adverse cardiovascular event over a follow-up of approximately five years vs. those who received placebo.

Momelotinib can be prescribed to treat intermediate- or high-risk myelofibrosis.

'Prevented estimated 800 hospitalizations and 60 deaths'

More patients are seeking abortion medication mifepristone outside the healthcare system as states restrict abortion access. Meanwhile, the Supreme Court heard oral arguments on the fate of mifepristone access.

'Over the past year, I have watched many children die of measles'

Stroke 2024: Advancing Therapy, Improving Outcomes provides evidence-based, cutting edge, clinical information on treating stroke and other neurological problems in a concise, accurate, and clinically relevant format. Written and edited by leading experts in the fields of neurology and emergency med...

Stroke 2023: Evolving Progress in Care provides evidence-based, cutting edge, clinical information on treating stroke and other neurological problems in a concise, accurate, and clinically relevant format. Written and edited by leading experts in the fields of neurology and emergency medicine, Strok...

STEMI Watch 2022: Strategic Advances in Care provides physicians and staff with a concise and practical update on ST-segment elevation myocardial infarction (STEMI).